Your browser doesn't support javascript.
loading
Nationwide surveillance system to evaluate hospital-acquired COVID-19 in Brazilian hospitals.
Machado de Miranda Costa, M; Guedes, A R; Nogueira, M D S P; Oliveira, L S C; de Souza Barros, L; Goncalves, M R S; Carvalho, A A; Amaral de Moura, H L C; Levin, A S; Oliveira, M S.
Afiliação
  • Machado de Miranda Costa M; Brazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
  • Guedes AR; Department of Infection Control of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Nogueira MDSP; Brazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
  • Oliveira LSC; Brazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
  • de Souza Barros L; Brazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
  • Goncalves MRS; Brazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
  • Carvalho AA; Brazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
  • Amaral de Moura HLC; Brazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
  • Levin AS; Department of Infection Control of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Oliveira MS; Department of Infection Control of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil. Electronic address: maura.oliveira@hc.fm.usp.br.
J Hosp Infect ; 123: 23-26, 2022 May.
Article em En | MEDLINE | ID: mdl-35176413
BACKGROUND: Although the risk of SARS-CoV-2 transmission within hospitals has been well recognized, there is a paucity of data on its occurrence. Our aim was to report the incidence of hospital-acquired (HA) COVID-19 at Brazilian hospitals. METHODS: We investigated the incidence of HA COVID-19 in Brazilian hospitals using data from a national surveillance system, from August 2020 through September 2021. Definitions of HA COVID-19 were: (1) symptom onset >14 days after hospital admission plus a positive SARS-CoV-2 RNA or antigen test; (2) symptom onset on days 8-14 after admission, plus a positive SARS-CoV-2 RNA or antigen test positive, plus documented high-risk exposure. We performed descriptive analyses and reported HA COVID-19 rates using pooled mean and percentile distribution. RESULTS: A total of 48,634 cases of HA COVID-19 were reported from 1428 hospitals. Incidence ranged from 0.16/1000 patient-days at neonatal intensive care units (ICUs) to 5.8/1000 patient-days at adult ICUs. The highest incidence of HA COVID-19 was during the months March to July 2021, similar to that which was observed for community-acquired COVID-19. CONCLUSIONS: This report provides a national view of the burden of HA COVID-19. The highest incidence of HA COVID-19 similar that which was observed for community-acquired COVID-19. We believe that this reflects the difficulty of implementing preventive measures. Further studies evaluating risk factors for the hospital transmission of SARS-Cov-2 should clarify strategies to minimize the risk of HA COVID-19 and may be applicable to other respiratory diseases. Furthermore, the implementation of a national system to evaluate HA COVID-19 has the potential to shine a light on this problem and lead to interventions in each hospital.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Adult / Humans / Newborn País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Hosp Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Adult / Humans / Newborn País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Hosp Infect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido